This report describes how viewing drug use as a health issue does not recognise the racism embedded within drug policy and the stigma associated with use.
This annual national report by Public Health England describes trends in infections and associated risks and behaviours amongst people who use drugs in the United Kingdom.
ReLeaf publishes a proposal that aims at providing local authorities with a brief overview of a regulated cannabis market for adult use and highlights the importance to enact legislative changes based on human rights and harm reduction principles.
The United Nations Office on Drugs and Crime analyses socio‐economic differences between villages that cultivate opium‐poppy and villages that do not in order to evaluate their status and living conditions.
The Eurasian Harm Reduction Association taken the case of Albania into consideration in order to analyse the challenges faced in sustaining HIV prevention programmes as a result of the withdrawal of the Global Fund.
The European Monitoring Centre for Drugs and Drug Addiction has published an update on the size of European illicit drug markets for cannabis, cocaine, MDMA, amphetamines and opioids.
The first independent evaluation of the ACT's pill testing trial occurred in 2019 at a Canberra music festival. Those in favour of pill testing argue in favour of a national trial, however, no other state or territory has shown interest in conducting similar trials.
Rights Reporter Foundation's survey of former NSP clients highlight the importance of tailored harm reduction services and addressing socio-structural barriers to health.
This publication provides Western Australia's Select Committee's suggestions into alternate approaches to reducing illicit drug use and its effects on the community.
